

SLU-PP-332 (500 mcg, 60 count)
$97.00
Contents: Lyophilized Powder in 3ml vial
Requires reconstitution with bacteriostatic water
Rigorous Third-Party Testing
Every batch of our research chemicals and peptides undergoes third-party testing.
- Description
- 3rd Party Lab Testing
Description
What is SLU-PP-332?
SLU-PP-332 is a small-molecule research compound currently under investigation for its role in regulating cellular energy metabolism. Preclinical research has examined SLU-PP-332 as a potential mitochondrial uncoupler and modulator of AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR) pathways.
Early laboratory studies suggest that SLU-PP-332 may influence oxidative phosphorylation efficiency, energy expenditure, and lipid metabolism. Research efforts aim to elucidate its role in mitochondrial biogenesis, cellular stress response, and metabolic regulation within controlled in vitro and animal model systems. SLU-PP-332 remains a strictly investigational compound, and additional data are required to fully characterize its biological activity.
SLU-PP-332 Product Specifications
| Specification | Details |
|---|---|
| Form | Capsules (60 count per container) |
| Strength | 500 mcg per capsule |
| Purity | >99% (HPLC Verified) |
| Appearance | White to off-white powder encapsulated in cellulose capsules |
| Storage Conditions | Store in a cool, dry place, away from direct light |
| Stability | 24 months if properly stored |
Why Choose BioEdge Research Labs SLU-PP-332?
- Research-Grade Quality: Verified > 99% purity by third-party HPLC testing to ensure analytical consistency.
- Precision Manufacturing: Produced in a cGMP-certified facility under strict quality control for research reliability.
- Secure Packaging: Encapsulated and sealed to protect compound integrity and prevent moisture exposure.
- Rapid Fulfillment: Most orders ship within 24 hours of payment confirmation from our U.S.-based facility.
Summary of Preclinical Research Findings
Mitochondrial Uncoupling & Energy Expenditure
SLU-PP-332 has been evaluated in preclinical studies for its capacity to mildly uncouple mitochondrial respiration, leading to increased energy expenditure and metabolic rate in experimental models. Research indicates potential regulation of oxidative phosphorylation and thermogenic signaling pathways.
AMPK & PPAR Pathway Activation
Investigations have suggested that SLU-PP-332 activates AMPK and PPARδ signaling, resulting in enhanced fatty acid oxidation and improved cellular energy balance. These findings support its use in laboratory exploration of metabolic modulation and mitochondrial health.
Lipid Metabolism & Glucose Regulation
Laboratory data demonstrate modulation of lipid synthesis and glucose utilization through AMPK-dependent mechanisms. SLU-PP-332’s effects on metabolic enzyme expression may provide valuable insight into lipid turnover, energy homeostasis, and mitochondrial efficiency.
Cellular Stress & Mitochondrial Biogenesis
Studies have shown that SLU-PP-332 may upregulate genes associated with mitochondrial biogenesis and antioxidant defense. Research models highlight improved cellular stress tolerance and increased expression of PGC-1α, a master regulator of mitochondrial function.
Systemic Metabolic Research Applications
Emerging preclinical data suggest potential relevance of SLU-PP-332 in metabolic and aging models, where mitochondrial uncoupling and energy regulation are central to understanding resilience and longevity pathways.
Suggested Research Applications
-
Mitochondrial uncoupling and bioenergetics studies
-
AMPK and PPAR pathway activation research
-
Lipid oxidation and glucose metabolism modeling
-
Cellular stress response and antioxidant signaling studies
-
Mitochondrial biogenesis and energy turnover experiments
-
Metabolic regulation and aging mechanism investigations
Applications listed above are for informational purposes only to assist qualified researchers in experimental design. No therapeutic or diagnostic implications are expressed or implied.
Handling & Storage Guidelines
-
Store capsules at room temperature.
-
Protect from direct light, heat, and moisture.
-
Use sterile handling practices in laboratory environments.
For Research Use Only
BioEdge Research Labs’ SLU-PP-332 is supplied exclusively for research and laboratory use.
-
Not for human or animal use
-
Not for medical or diagnostic purposes
-
Purchase confirms that the buyer is a qualified researcher, 18 years or older
-
All usage must comply with local laws and lab safety guidelines
Summary of References
Mitochondrial & ERR Signaling in Metabolic Regulation
-
Eissa, M. E. (2025). SLU-PP-332 AND RELATED ERRα AGONISTS: A focused minireview of metabolic regulation, and therapeutic potential. Universal Journal of Pharmaceutical Research, 10(3). https://ujpronline.com/index.php/journal/article/view/1355 UJP Research
-
Nasri, H. (2024). New hopes on “SLU-PP-332” as an effective agent for weight loss with indirect kidney protection efficacy; a nephrology point of view. Journal of Renal Endocrinology, 10, e25143. https://jrenendo.com/PDF/jre-10-e25143.pdf jrenendo.com
-
(2023). A Synthetic ERR Agonist Alleviates Metabolic Syndrome. Journal of Pharmacology & Experimental Therapeutics, (Article). https://www.sciencedirect.com/science/article/pii/S0022356524171583 sciencedirect.com
Muscle, Exercise & Energy Expenditure Research
-
(2024). An “exercise mimetic” synthetic compound in skeletal muscle: The roles of estrogen-related receptors in skeletal muscle fatigue associated with exercise and their potential therapeutic effects. Journal of Muscle & Strength Research, (Issue). https://jmsgr.tamhsc.edu/roles-of-estrogen-related-receptors-in-skeletal-muscle-fatigue-associated-with-exercise-and-their-potential-therapeutic-effects/
-
(2023). An abstract of metabolic / mitochondrial intervention in cardiovascular context. Circulation, 144(Suppl 1). https://www.ahajournals.org/doi/abs/10.1161/circ.144.suppl_1.9682 AHA Journals
Cellular & Preclinical Mechanistic Models
-
(2024). Synthetic agonist activity and mitochondrial modulation in preclinical cellular or tissue models. ScienceDirect. https://www.sciencedirect.com/science/article/pii/S0306987724001051
-
(2022). Preprint: ERR-agonist compound impacts mitochondrial biogenesis and cellular respiration under stress. bioRxiv. https://www.biorxiv.org/content/10.1101/2022.10.05.510974.abstract
BioEdge Research Labs
Precision. Purity. Performance.
At BioEdge, we are committed to providing research professionals with the highest quality peptides on the market. Every compound we supply is manufactured in a cGMP-certified facility, undergoes rigorous third-party testing, and is intended strictly for in vitro or laboratory research use only.





